Correction to: Nature Medicine https://doi.org/10.1038/s41591-025-03715-6, published online 27 May 2025.

In the version of the article initially published, the far-right column of the lower panel in Fig. 2c was missing and has now been added, as seen in Fig. 1, below. Additionally, the sentence “L.P. is a founder and shareholder of Apricot Therapeutics - a precision oncology spin-off from the University of Zurich - based on 4i drug response profiling” was missing from the Competing interests statement and has now been added. These corrections have been made to the HTML and PDF versions of the article.

Fig. 1
figure 1

Original and corrected Fig. 2c.

Full size image